F-star Biotechnology

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies, where the second binding site is in the constant Fc region of an antibody, offering unprecedented ease in the discovery, development and manufacturing of bispecific antibody products. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including, AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim.
Company Growth (employees)
Cambridgeshire, GB
Size (employees)
70 (est)-2%
F-star Biotechnology was founded in 2006 and is headquartered in Cambridgeshire, GB

Key People/Management at F-star Biotechnology

John Haurum

John Haurum

Eugen Stermetz

Eugen Stermetz

Jane Dancer

Jane Dancer


F-star Biotechnology Office Locations

F-star Biotechnology has offices in Cambridgeshire and Wien
Wien, AT
7 Schwarzenbergpl.

F-star Biotechnology Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$57.3 m

Latest funding size

$9.4 m

Time since last funding

about 4 years


F-star Biotechnology's latest funding round in October 2013 was reported to be $9.4 m. In total, F-star Biotechnology has raised $57.3 m

F-star Biotechnology Financials

F-star Biotechnology's revenue was reported to be £13.9 m in FY, 2016 which is a 79% increase from the previous period.

Revenue (FY, 2016)

13.9 m

Net income (FY, 2016)

(1.2 m)

Cash (31-Dec-2016)

1.1 m
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


405.2 k2.4 m7.1 m7.7 m13.9 m

Revenue growth, %


Pre tax profit

(1.2 m)(3.3 m)825.7 k(797.2 k)(1.5 m)

Income tax expense

132.5 k460.2 k6 k(20.1 k)397.8 k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


2.3 m1.2 m240.8 k1.3 m1.1 m

Accounts Receivable

405.2 k752.5 k65.2 k

Current Assets

3 m2.6 m2.8 m6.1 m4.3 m


463 k400.6 k491.7 k946.7 k1.4 m
    GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (1.1 m)(2.8 m)831.7 k(817.3 k)(1.2 m)

    Cash From Operating Activities

    (1.2 m)(887.6 k)(211.3 k)(1.4 m)299.1 k

    Cash From Financing Activities

    3.5 m(142.6 k)(443.3 k)4.6 m(145.5 k)

    Net Change in Cash

    2.3 m(1.1 m)(925.6 k)1 m(200.5 k)
      GBPY, 2016


      227.8 k

      Financial Leverage

      -11.5 x
      Show all financial metrics

      F-star Biotechnology's Web-traffic and Trends

      F-star Biotechnology Online and Social Media Presence

      F-star Biotechnology Company Life and Culture

      You may also be interested in